Nicolas Penel Selected Research

Platinum

10/2021	Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial.
1/2019	Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
12/2013	Nomogram to predict treatment outcome of fluoropyrimidine/platinum-based chemotherapy in metastatic esophageal squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolas Penel Research Topics

Disease

74	Neoplasms (Cancer) 03/2024 - 06/2004
54	Sarcoma (Soft Tissue Sarcoma) 12/2023 - 08/2006
22	Neoplasm Metastasis (Metastasis) 10/2023 - 06/2003
12	Disease Progression 01/2023 - 04/2015
11	Leiomyosarcoma 01/2022 - 08/2006
10	Hemangiosarcoma (Angiosarcoma) 09/2020 - 12/2007
9	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 02/2012
9	Neutropenia 01/2022 - 11/2008
8	Hypertension (High Blood Pressure) 01/2022 - 12/2016
7	Fatigue 06/2023 - 07/2013
7	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2023 - 01/2009
7	Aggressive Fibromatosis (Desmoid) 01/2021 - 03/2017
6	Thrombocytopenia (Thrombopenia) 12/2023 - 07/2013
6	Carcinoma (Carcinomatosis) 01/2023 - 06/2003
6	Melanoma (Melanoma, Malignant) 01/2023 - 10/2010
6	Osteosarcoma (Osteogenic Sarcoma) 11/2022 - 08/2016
5	Chordoma 10/2023 - 07/2015
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2019
5	Infections 11/2020 - 04/2002
5	Breast Neoplasms (Breast Cancer) 01/2014 - 06/2003
4	Asthenia 12/2023 - 12/2016
4	Liposarcoma 01/2022 - 11/2012
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 04/2002
4	Nausea 01/2022 - 11/2008
3	Ewing Sarcoma (Sarcoma, Ewing) 12/2023 - 01/2020
3	Pain (Aches) 12/2023 - 01/2017
3	Microsatellite Instability 01/2023 - 01/2020
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 12/2016
3	Pneumonia (Pneumonitis) 01/2022 - 07/2013
3	Uveal melanoma 01/2022 - 12/2008
3	Brain Neoplasms (Brain Tumor) 01/2022 - 12/2012
3	Febrile Neutropenia 01/2022 - 04/2015
3	Renal Cell Carcinoma (Grawitz Tumor) 10/2021 - 12/2012
3	Squamous Cell Carcinoma of Head and Neck 10/2021 - 10/2019
3	Esophageal Squamous Cell Carcinoma 01/2021 - 12/2013
3	Adenocarcinoma 01/2021 - 01/2019
3	Fibroma (Fibromatosis) 01/2021 - 11/2019
3	Head and Neck Neoplasms (Head and Neck Cancer) 06/2008 - 06/2004
2	Exanthema (Rash) 01/2023 - 07/2013
2	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 01/2022
2	Carcinogenesis 01/2022 - 01/2022
2	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 01/2010
2	Phyllodes Tumor (Cystosarcoma Phylloides) 06/2020 - 05/2020
2	Margins of Excision 06/2020 - 10/2018

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2012
14	TrabectedinIBA 01/2022 - 08/2010
13	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 06/2008
12	regorafenibIBA 12/2023 - 11/2013
12	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2006
9	pembrolizumabIBA 10/2023 - 12/2018
9	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 11/2011
8	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
8	Tyrosine Kinase InhibitorsIBA 11/2022 - 12/2012
7	Ifosfamide FDA LinkGeneric 10/2020 - 08/2006
7	Paclitaxel (Taxol)FDA LinkGeneric 10/2018 - 12/2007
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2014
6	Sunitinib (Sutent)FDA Link 12/2022 - 11/2014
6	Docetaxel (Taxotere)FDA Link 06/2017 - 08/2006
5	B7-H1 AntigenIBA 01/2023 - 12/2018
5	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2015
5	pazopanib FDA Link 01/2021 - 01/2019
5	AnthracyclinesIBA 01/2019 - 11/2008
4	Carboplatin (JM8)FDA LinkGeneric 01/2024 - 05/2009
4	Taxoids (Taxanes)IBA 01/2023 - 12/2007
4	RamucirumabIBA 01/2021 - 12/2018
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2020 - 03/2015
4	Gemcitabine FDA Link 12/2018 - 08/2006
3	enzalutamideIBA 06/2023 - 06/2017
3	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2020
3	Immunoglobulin G (IgG)IBA 01/2022 - 01/2019
3	PlatinumIBA 10/2021 - 12/2013
3	Bevacizumab (Avastin)FDA Link 09/2020 - 09/2015
3	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 10/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 09/2014
3	Alanine Transaminase (SGPT)IBA 01/2019 - 03/2015
3	AlbuminsIBA 01/2016 - 03/2012
2	Androgen Receptors (Androgen Receptor)IBA 06/2023 - 01/2023
2	RogaratinibIBA 01/2023 - 10/2019
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2023 - 10/2019
2	Messenger RNA (mRNA)IBA 01/2023 - 10/2019
2	abirateroneIBA 01/2022 - 06/2017
2	LigandsIBA 10/2021 - 03/2018
2	Phosphotransferases (Kinase)IBA 01/2021 - 09/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2020 - 09/2004
2	Midazolam (Versed)FDA LinkGeneric 10/2020 - 06/2020
2	Vinorelbine (Navelbine)FDA LinkGeneric 09/2020 - 11/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2020 - 10/2010

Therapy/Procedure

39	Drug Therapy (Chemotherapy) 10/2023 - 04/2002
34	Therapeutics 01/2023 - 06/2003
16	Radiotherapy 12/2022 - 04/2002
7	Immunotherapy 01/2023 - 05/2015
4	Molecular Targeted Therapy 06/2020 - 01/2012
4	Adjuvant Radiotherapy 01/2016 - 09/2008
3	Castration 01/2024 - 06/2017
3	Palliative Care (Palliative Therapy) 01/2021 - 09/2015
3	Adjuvant Chemotherapy 06/2020 - 01/2018
3	Aftercare (After-Treatment) 01/2019 - 01/2014
3	Antibiotic Prophylaxis 03/2009 - 05/2004
3	Operative Surgical Procedures 06/2008 - 03/2005
2	Length of Stay 11/2020 - 06/2008